Detalhe da pesquisa
1.
Candidate variants in DNA replication and repair genes in early-onset renal cell carcinoma patients referred for germline testing.
BMC Genomics
; 24(1): 212, 2023 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37095444
2.
CRISPR/Cas9 genome-wide loss-of-function screening identifies druggable cellular factors involved in sunitinib resistance in renal cell carcinoma.
Br J Cancer
; 123(12): 1749-1756, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32968206
3.
Ganetespib limits ciliation and cystogenesis in autosomal-dominant polycystic kidney disease (ADPKD).
FASEB J
; 32(5): 2735-2746, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29401581
4.
Musashi-2 (MSI2) supports TGF-ß signaling and inhibits claudins to promote non-small cell lung cancer (NSCLC) metastasis.
Proc Natl Acad Sci U S A
; 113(25): 6955-60, 2016 06 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-27274057
5.
Correction: Candidate variants in DNA replication and repair genes in early-onset renal cell carcinoma patients referred for germline testing.
BMC Genomics
; 24(1): 388, 2023 Jul 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37430226
6.
Genetic Variants That Predispose to DNA Double-Strand Breaks in Lymphocytes From a Subset of Patients With Familial Colorectal Carcinomas.
Gastroenterology
; 149(7): 1872-1883.e9, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26344056
7.
Inhibiting the HSP90 chaperone slows cyst growth in a mouse model of autosomal dominant polycystic kidney disease.
Proc Natl Acad Sci U S A
; 110(31): 12786-91, 2013 Jul 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-23858461
8.
Compounds identified by virtual docking to a tetrameric EGFR extracellular domain can modulate Grb2 internalization.
BMC Cancer
; 15: 436, 2015 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-26016476
9.
Aurora A kinase (AURKA) in normal and pathological cell division.
Cell Mol Life Sci
; 70(4): 661-87, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22864622
10.
Aurora kinases in head and neck cancer.
Lancet Oncol
; 14(10): e425-35, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23993387
11.
Synergy of EGFR and AURKA Inhibitors in KRAS-mutated Non-small Cell Lung Cancers.
Cancer Res Commun
; 4(5): 1227-1239, 2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38639476
12.
Source, co-occurrence, and prognostic value of PTEN mutations or loss in colorectal cancer.
NPJ Genom Med
; 8(1): 40, 2023 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38001126
13.
Protein-intrinsic and signaling network-based sources of resistance to EGFR- and ErbB family-targeted therapies in head and neck cancer.
Drug Resist Updat
; 14(6): 260-79, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21920801
14.
Comprehensive characterization of PTEN mutational profile in a series of 34,129 colorectal cancers.
Nat Commun
; 13(1): 1618, 2022 03 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35338148
15.
Association of TP53 and CDKN2A Mutation Profile with Tumor Mutation Burden in Head and Neck Cancer.
Clin Cancer Res
; 28(9): 1925-1937, 2022 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35491653
16.
Nedd9 Restrains Autophagy to Limit Growth of Early Stage Non-Small Cell Lung Cancer.
Cancer Res
; 81(13): 3717-3726, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34006524
17.
Design, synthesis and biological evaluation of 2-quinolyl-1,3-tropolone derivatives as new anti-cancer agents.
RSC Adv
; 11(8): 4555-4571, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33996031
18.
Musashi-2 (MSI2) regulates epidermal growth factor receptor (EGFR) expression and response to EGFR inhibitors in EGFR-mutated non-small cell lung cancer (NSCLC).
Oncogenesis
; 10(3): 29, 2021 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33723247
19.
Formation of MacroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA.
Dev Cell
; 8(1): 19-30, 2005 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-15621527
20.
Identification of the KRIT1 Protein by LexA-Based Yeast Two-Hybrid System.
Methods Mol Biol
; 2152: 269-289, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32524559